Projects per year
Fingerprint Dive into the research topics where M Maral Mouradian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 11 Similar Profiles
Parkinson Disease
Medicine & Life Sciences
Levodopa
Medicine & Life Sciences
Synucleins
Medicine & Life Sciences
Dopamine Receptors
Medicine & Life Sciences
Dyskinesias
Medicine & Life Sciences
Dopamine
Medicine & Life Sciences
Genes
Medicine & Life Sciences
Corpus Striatum
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2006 2022
PP2A Dysregulation in the Pathogenesis of alpha-Synucleinopathies
Mouradian, M. M. & Nicholls, R.
5/1/17 → 4/30/22
Project: Research project
Protein Phosphatase 2
Synucleins
Methylation
Serine
Virulence
MOLECULAR REGULATION OF TRANSMITTER RECEPTOR GENES
Mouradian, M. M. & Chase, T.
Project: Research project
Genes
alpha-Synuclein
Brain-Derived Neurotrophic Factor
Parkinson Disease
Cell Death
Developing Novel RNA-Based Therapeutics for Parkinson's Disease
Mouradian, M. M. & Disney, M.
12/15/16 → 11/30/19
Project: Research project
Synucleins
Parkinson Disease
RNA
Therapeutics
Medical Genetics
Synergistic Neuroprotective Mechanisms of Coffee Components in Parkinson's Diseas
Mouradian, M. M. & Stock, J.
9/30/12 → 8/31/18
Project: Research project
Coffee
Caffeine
Parkinson Disease
Dietary Supplements
Synucleins
Manipulating Gene Expression in the Dyskinesias of Parkinson's Disease
Mouradian, M. M. & Papa, S.
9/1/11 → 7/31/18
Project: Research project
Dyskinesias
Parkinson Disease
Gene Expression
Primates
Haplorhini
Research Output 1986 2020
Apoptosis signal regulating kinase 1 deletion mitigates α-synuclein pre-formed fibril propagation in mice
Zhang, J., Park, E. S., Park, H. J., Yan, R., Grudniewska, M., Zhang, X., Oh, S., Yang, X., Baum, J. & Mouradian, M. M., Jan 2020, In : Neurobiology of Aging. 85, p. 49-57 9 p.Research output: Contribution to journal › Article
MAP Kinase Kinase Kinase 5
Synucleins
Disease Progression
Injections
Parkinson Disease
Letter from the Editor-in-Chief: Growth of the Journal
Mouradian, M. M., Jan 1 2019, (Accepted/In press) In : Neurotherapeutics.Research output: Contribution to journal › Editorial
Open Access
Growth
3
Citations
(Scopus)
Nucleic Acid–Based Therapeutics for Parkinson’s Disease
Nakamori, M., Junn, E., Mochizuki, H. & Mouradian, M. M., Apr 15 2019, In : Neurotherapeutics. 16, 2, p. 287-298 12 p.Research output: Contribution to journal › Review article
Synucleins
Parkinson Disease
Dopamine
Dopaminergic Neurons
Small Interfering RNA
1
Citation
(Scopus)
Role of striatal ΔFosB in L-Dopa–induced dyskinesias of parkinsonian nonhuman primates
Beck, G., Singh, A., Zhang, J., Potts, L. F., Woo, J. M., Park, E. S., Mochizuki, H., Maral Mouradian, M. & Papa, S. M., Sep 10 2019, In : Proceedings of the National Academy of Sciences of the United States of America. 116, 37, p. 18664-18672 9 p.Research output: Contribution to journal › Article
Open Access
Corpus Striatum
Dyskinesias
Primates
Levodopa
Dopamine
28
Citations
(Scopus)
Cytoprotective mechanisms of DJ-1 against oxidative stress through modulating ERK1/2 and ASK1 signal transduction
Oh, S. E. & Mouradian, M. M., Apr 1 2018, In : Redox Biology. 14, p. 211-217 7 p.Research output: Contribution to journal › Review article
MAP Kinase Kinase Kinase 5
Signal transduction
Oxidative stress
Signal Transduction
Oxidative Stress